January 19, 2022
Ceptur Therapeutics Launches with $75 Million to Advance Novel RNA Therapeutics
Read More
January 19, 2022
64x Bio Raises $55 Million to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing
Read More
January 18, 2022
Ori Biotech Raises $100+ Million to Launch Novel Cell/Gene Therapy Manufacturing Platform
Read More
January 11, 2022
Rare Disease Drug Developers Raised $22.9 billion in 2021, a 28 Percent Increase over Previous Year
Read More
January 11, 2022
South Korean Conglomerate SK Pumps $350 million in Center for Breakthrough Medicines
Read More
January 10, 2022
Maze Therapeutics Raises $190 Million to Advance Programs and Platform for Genetic Diseases
Read More
January 7, 2022
Two Neurodegenerative Disease Biotechs, Amylyx and Vigil, Raise Combined $288 Million in IPOs
Read More
January 7, 2022
AN2 Closes $80 Million Financing to Advance Nontuberculous Mycobacterial Lung Disease Program
Read More
January 5, 2022
SalioGen Raises $115 Million to Advance Gene Coding, a New Category of Genetic Medicine
Read More
January 5, 2022
Korro Bio Raises $116 Million to Advance Pipeline of RNA Editing Programs
Read More
January 4, 2022
Scandinavian Rare Disease Venture Fund Launches with $124 Million
Read More
January 4, 2022
Cystic Fibrosis Foundation Awards BiomX up to $5 Million to Support Phage Therapies for Respiratory Infections
Read More
Load More
X